← Open Payments lookup

ZHAN YANG: Open Payments

NPI 1508205618 · BUDA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,363 in 250 payments from 23 companies in 2025. Trend: 2023 $5,096 · 2024 $3,813 · 2025 $4,363

Food & beverage: $4,363
CompanyPaymentsAmount
Alkermes, Inc.32$644
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$511
Otsuka America Pharmaceutical, Inc.29$495
Teva Pharmaceuticals USA, Inc.22$350
ABBVIE INC.22$318
Vanda Pharmaceuticals Inc.23$293
E.R. Squibb & Sons, L.L.C.14$287
Axsome Therapeutics, Inc.13$254
Neurocrine BioSciences, Inc.18$228
Janssen Pharmaceuticals, Inc15$217

Products named: CAPLYTA, REXULTI, ARISTADA, VRAYLAR, FANAPT, COBENFY, UZEDY, INGREZZA.

Industry payments across TX — which companies pay providers there.